iBio, Inc. — Investor Relations & Filings
Filings indexed
690
across all filing types
Latest filing
2026-04-29
Regulatory Filings
Country
US
United States of America
Listing
US
IBIO
iBio, Inc. is a preclinical-stage biotechnology company that utilizes a proprietary, AI-driven drug discovery platform to develop novel antibody therapeutics. The company focuses on creating next-generation medicines for obesity and cardiometabolic disorders, aiming to enhance metabolic health. Its technology stack integrates artificial intelligence, machine learning, and advanced computational biology to accelerate the discovery and optimization of biopharmaceuticals for difficult-to-drug targets. The company's internal pipeline consists of therapeutic candidates developed using this platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | |
| 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | |
| S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38584987 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | ||
| 33816158 | 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | ||
| 33012910 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 33012908 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 32891626 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 32891629 | S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 29659150 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29659058 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29658712 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32891630 | 10-Q - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 32891628 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 19423077 | EFFECT - iBio, Inc. (0001420720) (Filer) | 2026-02-10 | English | ||
| 18510814 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-02-09 | English | ||
| 32891624 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
| 32891625 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
iBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35045/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35045 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35045 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35045 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35045}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for iBio, Inc. (id: 35045)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.